The companies say the drug, now in late-stage clinical trials, could be more effective for pain treatment than opioids—a dangerous category of pain killers that includes hydrocodone, morphine and fentanyl—without the abuse potential of such medications.
The Indiana Department of Insurance has yet to approve the insurers’ proposed higher rates, which will be for those buying individual plans on the Affordable Care Act marketplace next year.
The proposal would provide an additional $50 billion over four years to stabilize insurance exchanges, relying on a mechanism Republicans have criticized in the past as a way to keep insurers in the marketplace.
Top Senate Republicans prepared Wednesday to release their plan for dismantling President Barack Obama’s health care law.
Two Indianapolis-based health insurers are pulling out of Indiana’s insurance exchanges next year, citing growing uncertainty over the future of the Affordable Care Act. Together, they represent about 77,000 members who now must find other plans.
America's three insulin manufacturers—Indianapolis-based Eli Lilly and Co., Sanofi and Novo Nordisk—would face fines of $5,000 daily if they fail to provide the data.
Indiana hospitals are bracing for congressional action that could mean deep cuts in Medicaid, which funds the state’s popular health insurance program for low-income adults.
In statehouses across the country and in Congress, drugmaker Alkermes is pushing its own addiction treatment while contributing to misconceptions and stigma about other medications used to treat opioid addiction.
The court's unanimous ruling Monday means a loss of billions in sales to makers of original versions of biologic drugs.
Besides contributing to overdoses, abuse of Opana ER was blamed for a 2015 outbreak of HIV and hepatitis C in southern Indiana linked to sharing needles, according to the FDA.
Just weeks after abandoning its proposed $48 billion merger with rival Cigna Corp., the Indianapolis-based health insurer is looking for its next deal. But this time, it is likely to be much smaller.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
Planned Parenthood of Indiana and Kentucky Inc. on Tuesday announced the hiring of a veteran not-for-profit leader to replace Betty Cockrum, who is retiring after 15 years as president and CEO of the organization.
A set of consolidated lawsuits accuse AbbVie and other makers of testosterone-replacement medicines, including Eli Lilly and Co., of hiding or downplaying their products’ risk for blood clots or other serious injuries.
Religious hospitals don't have to comply with federal laws protecting pension plans, a unanimous Supreme Court ruled Monday in a case that affects retirement benefits for roughly a million workers.
The first case against Bloomington-based Cook Group from patients who say the company’s blood-clot filters malfunctioned is headed for trial this fall in Indianapolis.
Most of the cuts this summer will come from the hospital system’s billing operations in Indianapolis.
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.
